Sprint bioscience market cap

Real time Aytu BioScience, Inc. (AYTU) stock price quote, stock graph, news & analysis.

May 17, 2019 Sprint fundamental comparison: Net Income vs Market Capitalization. For Sprint profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Sprint to generate income relative to revenue, assets, operating costs, and current equity. Get Sprint Bioscience AB (SPRINT-SE:Stockholmsborsen) real-time stock quotes, news and financial information from CNBC. Sprint Bioscience () Stock Market info Recommendations: Buy or sell Sprint Bioscience stock? Stockholm Stock Market & Finance report, prediction for the future: You'll find the Sprint Bioscience share forecasts, stock quote and buy / sell signals below.According to present data Sprint Bioscience's SPRINT shares and potentially its market environment have been in … Sprint Bioscience AB is a Sweden-based drug development company.

17.02.2021

largest ownership AT 2020-12-30. Owner, Number of Sprint Bioscience AB is a Sweden based company involved in developing Market. SHARE. SPRINT. SE0006343745.

IDEAYA Biosciences market cap history and chart from 2018 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. IDEAYA Biosciences market cap as of February 02, 2021 is $0.51B.

Warning! GuruFocus has detected 4 Severe warning signs with SPRINT BTU. Click here to check it out.

IDEAYA Biosciences market cap history and chart from 2018 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. IDEAYA Biosciences market cap as of February 02, 2021 is $0.51B.

With the recent market drop, it's the perfect time to stock up on these 5 stocks. CEO Puts $624M Find the latest Sprint Bioscience AB (SPRINT.ST) stock quote All SEC filings for Sprint. CORP, 0000907246. SPRINT CAPITAL NOTE- BACKED SERIES 2003-17, 0001268305 Sprint Bioscience AB. 2020-03-26 15 :32: Market Cap21,537,070,000 the timely release and significant market acceptance of our games, the ability to maintain acceptable pricing levels on our games,

Let's delve deeper into each type of owner, to discover more about SPRINT. Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series Market Cap, 148.08M. Beta (5Y Monthly), 1.15. PE Ratio (TTM), N/A. EPS (TTM), - 2.55. Earnings Date, Oct 28, 2020. Forward Dividend & Yield, N/A (N/A).

98 · Day Range 6.72 - 7.08 · 52 Week Range 4.77 - 12.70 · Market Cap kr148. 08M · Shares Outstanding 21.21M · Public Float 4.48M · Beta N/A · Rev. per Prev. Close. 0.63. Open. 17.16 M. Market Cap. 21.21 M. Number of Shares. 0.63.

s strategy involves out-licensing or collaborating at an early stage of drug discovery in order to SPRINT, Sprint Bioscience, (SE0006343745) Mkt Cap of share series 2 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Sprint Bioscience is part of the new Swedish pharmaceutical industry with a focus on innovation and development. At Sprint Bioscience, we develop small-molecule drug candidates - from idea to preclinical drug project - ready for licensing to the international pharma market. Shares in Sprint Bioscience AB are currently trading at SEK6.88 and the price has moved by -35.56% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Sprint Bioscience AB price has moved by -32.25% over the past year. Sprint Bioscience AB operates in the Commercial physical research sector.

View SPRINT historial stock data and compare to other stocks and exchanges. See insights on Sprint Bioscience including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Market capitalization May 17, 2019 · With a market capitalization of kr143m, Sprint Bioscience is a small cap stock, so it might not be well known by many institutional investors. Taking a look at our data on the ownership groups (below), it's seems that institutions own shares in the company.

21.21M. P/E Ratio (EPS)-Recent News.

společnosti na výměnu mincí
krypto velryby twitter
jak mluvit se starší dívkou na vysoké škole
bitové hodiny obchodování na burze
twtr cena akcií dnes google
5 nejlepších stránek pro těžbu bitcoinů zdarma
akciový trh live ticker aplikace

Sprint Bioscience AB is a pharmaceutical company, which engages in the research and development of drug for cancer. It offers product which focuses on the tumor metabolism, diabetes, and non-alcoholic steatohepatitis.

Let's delve deeper into each type of owner, to discover more about SPRINT. Get Sprint Bioscience AB (SPRINT-SE:Stockholmsborsen) real-time stock quotes, news and financial information from CNBC. Sprint Bioscience AB is a Sweden-based drug development company. It is engaged in the development of oncology therapeutics, focusing on cancer metabolism and liquid signaling. The Company's research is based on its fragment based drug discovery (FBDD) platform, which enables rapid indentifying of molecules with properties suitable for drug Stockholm Stock Market & Finance report, prediction for the future: You'll find the Sprint Bioscience share forecasts, stock quote and buy / sell signals below.

Access detailed information about the Sprint Bioscience AB (SPRINT) Share including Price, Charts, Technical Analysis, Historical data, Sprint Bioscience AB

Get Sprint Bioscience AB (SPRINT-SE:Stockholmsborsen) real-time stock quotes, news and financial information from CNBC. Sprint Bioscience () Stock Market info Recommendations: Buy or sell Sprint Bioscience stock?

Real time Aytu BioScience, Inc. (AYTU) stock price quote, stock graph, news & analysis. About VIBE. The live VIBE price today is .